Valens Credit Weekly Insights for September 14, 2016
Each week the Valens Credit team highlights our most interesting insights from across our tools and our analysis. This week interesting insights include:
Credit and Market Mispricings
Most Compelling Credit v Equity Market Mispricings
AN, CYH, NAV, SGMS, THC
Most Compelling Credit Rating Dislocations
EXPE, GM, JCP, TSX:MEG, R, TWTR, UIS, VRX, X, YRCW
Most Compelling CDS Market Mispricings
AVP, AMD, CHK, HNT, NAV, PKD, RIG, SHLD, UIS, X
Most Compelling Bond Market Mispricings
AKS, AMD, ATW, CHK, MDR, TSX:MEG, NAV, RIG, SVU, VRX
Highlighted Top Ideas
AMAG – AMAG Pharmaceuticals, Inc.
RPM – RPM International Inc.
Other Recent Analyses
Consumer Discretionary
EXPE – Expedia, Inc.
Consumer Staples
SVU – SUPERVALU INC.
Quantitative Credit Outlier Report Review
CHK, NAV, and X top our quantitative outlier report this week.
Aggregate Credit Market and Credit Fundamental Review
IG markets are currently fairly valued, as are HY markets. However, even after XO CDS has normalized in the last several months, it remains substantially above XO iCDS levels. This indicates that the XO market is overstating credit risk.
If you are interested in seeing any of the highlighted analyses, please contact the Valens team at valens@valens-securities.com